HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kenji Suzuki Hisao Asamura Ryosuke Tsuchiya Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakurai, H. Articles by Tsuchiya, R. Search for Related Content PubMed PubMed Citation Articles by Sakurai, H. Articles by Tsuchiya, R. Related Collections Education History Lung - other Trachea and bronchi

Eur J Cardiothorac Surg 2004;25:155-159
© 2004 Elsevier Science NL

Inflammatory myofibroblastic tumor of the lung

^a Division of Thoracic Surgery, National Cancer Center Hospital, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan
^b Division of Pathology, National Cancer Center Hospital, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan

Received 30 August 2003; received in revised form 21 October 2003; accepted 22 October 2003.

^* Corresponding author. Tel.: +81-3-3542-2511; fax: +81-3-3542-3815
e-mail: sakuraihm{at}ybb.ne.jp

Objective: Inflammatory myofibroblastic tumor (IMT) is a rare disease that usually occurs in the lung. Recently, several reports have suggested that IMT is a true neoplasm rather than a reactive lesion. In this retrospective study, we reviewed clinicopathological characteristics and prognoses for all patients with surgically resected IMT of the lung at our institute. Methods: From January 1985 to December 2002, nine patients had surgical intervention for IMT of the lung at the National Cancer Center Hospital, Tokyo. The resected lesions were studied histologically, immunohistochemically, and ultrastructurally. Follow-up was complete in all patients and varied from 3 months to 16 years 2 months (median, 6 years 2 months). Results: These nine patients included five men and four women. They ranged in age from 25 to 66 years. Seven patients were asymptomatic. The two symptomatic patients had problems including cough, hemoptysis, and dyspnea. For all these patients, the diagnostic procedure was surgical excision. The resected tumor size ranged from 1.0 to 4.0 cm in diameter. Histologically, a variety of inflammatory and spindle cells were observed. The spindle cells corresponded ultrastructurally to myofibroblasts or fibroblasts. With the exception of one patient who had spontaneous resolution of a recurrent tumor, there was no recurrence in these patients, and all of them are in good health. Conclusions: Histopathologically, IMT is characterized by myofibroblasts that are mixed with chronic inflammatory cells, including plasma cells, lymphocytes, and histiocytes. Surgical resection, when possible, can be chosen as the treatment. Complete resection leads to excellent survival.

Key Words: Lung pathology • Surgery • Survival • Inflammatory pseudotumor • Pulmonary neoplasm

This article has been cited by other articles:

				S.-i. Takeda, Y. Onishi, T. Kawamura, and H. Maeda Clinical spectrum of pulmonary inflammatory myofibroblastic tumor Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 629 - 633. [Abstract] [Full Text] [PDF]

				G. Melloni, A. Carretta, P. Ciriaco, G. Arrigoni, S. Fieschi, N. Rizzo, E. Bonacina, G. Augello, P. A. Belloni, and P. Zannini Inflammatory Pseudotumor of the Lung in Adults Ann. Thorac. Surg., February 1, 2005; 79(2): 426 - 432. [Abstract] [Full Text] [PDF]